Evolution of the Average Target: XP Inc.

Evolution of the Average Target - XP Inc.

Evolution of the Target Price: XP Inc.

Evolution of the Target Price - XP Inc.

Changes in Analyst Recommendations: XP Inc.

f1d7f6d.hnoFZqt8rOgrH75on0q3PeCPrMWQ3qEVe3T7HAf3AYE.4hlqA84tyIl5Sd9Y5wT8VIvc4aLp7cZgLiXOW2OwS-XcNVYw2CqZglpR6w~5a6005884498dcf62b5eef0c64d1f5b6
08/10 UBS Adjusts Price Target on XP to $37 From $25, Keeps Buy Rating MT
07/10 XP Shares Rise After Itau BBA Upgrade MT
06/10 Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts Price Target to $27 From $19 MT
31/08 Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts PT to $22 From $19 MT
02/04 UBS Adjusts Price Target on XP to $28 From $25, Maintains Buy Rating MT
20/01 Jefferies Initiates XP at Buy With $22 Price Target MT
16/12 UBS Adjusts XP Price Target to $25 From $23, Maintains Buy Rating MT
16/25/16 UBS Adjusts Price Target on XP to $23 From $24, Maintains Buy Rating MT
24/25/24 XP Shares Drop After Downgrade From Itau BBA MT
23/25/23 Itau BBA Downgrades XP to Market Perform From Outperform, Adjusts Price Target to $21 From $20 MT
10/25/10 UBS Adjusts XP Price Target to $24 From $17, Maintains Buy Rating MT
04/25/04 Goldman Sachs Upgrades XP to Buy From Neutral, $23 Price Target MT
13/25/13 XP Shares Rise After Morgan Stanley Upgrades to Overweight From Equalweight MT
13/25/13 Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18 MT
07/25/07 UBS Adjusts Price Target on XP to $17 From $16, Keeps Buy Rating MT
18/25/18 Itau BBA Initiates XP at Outperform With $20 Price Target MT
25/25/25 XP Shares Rise After Upgrade From UBS MT
24/25/24 UBS Upgrades XP to Buy From Neutral, Cuts Price Target to $16 From $19 MT
10/24/10 BofA Securities Downgrades XP to Neutral From Buy, Price Target is $16 MT
25/24/25 UBS Cuts Price Target on XP to $19 From $21, Maintains Neutral Rating MT
11/24/11 UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30 MT
05/24/05 Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31 MT
05/24/05 Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating MT
01/24/01 XP Shares Decline After Goldman Sachs Downgrade MT
30/24/30 Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-7.69%
+17.58%
+17.75%
+24.95%
+29.82%
-5.65%
+44.66%
+33.92%
+51.8%
+30.37%
Average +23.75%
Weighted average by Cap. +22.13%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
153.19BRL
Average target price
141.41BRL
Spread / Average Target
-7.69%
High Price Target
190.94BRL
Spread / Highest target
+24.64%
Low Price Target
104.97BRL
Spread / Lowest Target
-31.48%

Analyst Consensus Detail

Analyst consensus - XP Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - XP Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - XP Inc.